<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute mastoiditis in children: Treatment and prevention
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute mastoiditis in children: Treatment and prevention
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute mastoiditis in children: Treatment and prevention
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ellen R Wald, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna H Messner, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 05, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute mastoiditis is the most common suppurative complication of acute otitis media (AOM) [
         <a href="#rid1">
          1
         </a>
         ]. In many cases, it is the first evidence of AOM [
         <a href="#rid2">
          2-4
         </a>
         ].
        </p>
        <p>
         The treatment and prevention of acute mastoiditis in children are discussed below. The clinical features and diagnosis of acute mastoiditis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
         AOM is also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6009.html" rel="external">
          "Acute otitis media in children: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5959.html" rel="external">
          "Acute otitis media in children: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mastoiditis
         </strong>
         is a suppurative infection of the mastoid air cells.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute mastoiditis
         </strong>
         is a suppurative infection of the mastoid air cells with symptoms of less than one month's duration. Acute mastoiditis is subdivided according to the pathologic stage (see
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Pathogenesis'
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute mastoiditis with periostitis
         </strong>
         (also called incipient mastoiditis) is defined by the presence of purulent material in the mastoid cavities without destruction of the bony septa. The finding of fluid in the mastoid air cells on imaging is nonspecific and is commonly seen in children with acute otitis media (AOM) or otitis media with effusion. Thus, this finding alone is not diagnostic of mastoiditis. The diagnosis is based on clinical findings, including postauricular tenderness, erythema, and swelling with protrusion of the auricle (
         <a class="graphic graphic_picture graphicRef83205" href="/z/d/graphic/83205.html" rel="external">
          picture 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Coalescent mastoiditis
         </strong>
         (also called "acute mastoid osteitis") is defined by destruction of the thin bony septae between air cells (
         <a class="graphic graphic_diagnosticimage graphicRef83573" href="/z/d/graphic/83573.html" rel="external">
          image 1
         </a>
         ). This imaging finding is diagnostic of mastoiditis; however, most children do not require imaging to make the diagnosis (see
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Indications for imaging'
         </a>
         ). Coalescent mastoiditis may be followed by the formation of abscess cavities and the dissection of pus into adjacent areas, the most common of which is subperiosteal abscess.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subacute mastoiditis
         </strong>
         (also called "masked mastoiditis") refers to low-grade but persistent infection in the middle ear and mastoid with destruction of the bony septae between air cells [
         <a href="#rid5">
          5
         </a>
         ]. It occurs in patients with persistent otitis media with effusion or recurrent episodes of AOM without sufficient antimicrobial therapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic mastoiditis
         </strong>
         is a suppurative infection of the mastoid air cells of longstanding duration (months to years) [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complicated mastoiditis
         </strong>
         refers to mastoiditis with one or more extracranial or intracranial complications (
         <a class="graphic graphic_figure graphicRef83204" href="/z/d/graphic/83204.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The bacterial species most often implicated in acute mastoiditis are
         <em>
          Streptococcus
         </em>
         <em>
          pneumoniae
         </em>
         and
         <em>
          Streptococcus
         </em>
         <em>
          pyogenes
         </em>
         . Less commonly,
         <em>
          Fusobacterium
         </em>
         <em>
          necrophorum
         </em>
         ,
         <em>
          Haemophilus
         </em>
         <em>
          influenzae
         </em>
         (nontypeable),
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         (including methicillin-resistant
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         ), and
         <em>
          Pseudomonas
         </em>
         <em>
          aeruginosa
         </em>
         are recovered.
         <em>
          P
         </em>
         .
         <em>
          aeruginosa
         </em>
         is a consideration for children with a history of recurrent acute otitis media (AOM) or recent antibiotic use. Cultures performed on swabs of drainage from the external auditory canal are likely to be contaminated and may not reflect the true pathogenic organisms. The microbiology of acute mastoiditis in children is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Microbiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          MANAGEMENT APPROACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         The treatment of acute mastoiditis depends upon the stage as well as presence or absence and type of complications (
         <a class="graphic graphic_table graphicRef119748" href="/z/d/graphic/119748.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Pathogenesis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Complications'
         </a>
         .)
        </p>
        <p>
         Antimicrobial therapy and drainage of the middle ear and mastoid are the cornerstones of therapy for acute mastoiditis. However, treatment of acute mastoiditis in children has not been studied in randomized trials and the approach to management varies from center to center [
         <a href="#rid1">
          1
         </a>
         ]. The recommendations below are based upon information from observational studies [
         <a href="#rid3">
          3,8-14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Referral
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consultation with an otolaryngologist should occur early in the disease course [
         <a href="#rid1">
          1,6
         </a>
         ]. Aspiration and drainage of the middle ear are necessary for diagnostic and therapeutic purposes (see
         <a class="local">
          'Drainage'
         </a>
         below). Consultation with a neurosurgeon may be warranted for children with clinical or radiologic evidence of an intracranial complication. In addition, consultation with a pediatric infectious disease expert can help guide antimicrobial therapy.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Uncomplicated disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         For most children with uncomplicated acute or subacute (masked) mastoiditis, we suggest initial conservative management, consisting of intravenous (IV) antimicrobial therapy and middle ear drainage with myringotomy (with or without placement of a tympanostomy tube [TT]). (See
         <a class="local">
          'Antimicrobial therapy'
         </a>
         below and
         <a class="local">
          'Drainage'
         </a>
         below.)
        </p>
        <p>
         Most children with uncomplicated acute or subacute mastoiditis can be managed without mastoidectomy. However, patients should be monitored daily for clinical response and simple mastoidectomy should be performed if there is no clinical improvement in systemic and local findings within 48 hours. Imaging is not necessary for patients with uncomplicated disease unless they do not respond to treatment. (See
         <a class="local">
          'Treatment response'
         </a>
         below.)
        </p>
        <p>
         The practice of initial conservative management for children with uncomplicated mastoiditis is supported by several retrospective studies [
         <a href="#rid3">
          3,8-16
         </a>
         ]. The reported success rates of conservative therapy in these studies range from 60 to 97 percent. Most of the studies included a mix of patients with uncomplicated and complicated disease. Differences in the relative proportions of each likely explain the wide range in the reported success rates.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Complicated disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         For children with suppurative extracranial or intracranial complications of acute mastoiditis other than facial nerve paralysis, we suggest initial aggressive surgical management with mastoidectomy in addition to IV antimicrobial therapy and myringotomy (with TT insertion) rather than conservative management alone [
         <a href="#rid1">
          1,12,17,18
         </a>
         ].
        </p>
        <p>
         Suppurative complications include subperiosteal abscess, Bezold abscess (a neck abscess located beneath the sternocleidomastoid and digastric muscles), osteomyelitis involving other parts of the skull, suppurative labyrinthitis, meningitis, subdural abscess, epidural abscess, brain abscess, cerebellar abscess, or septic dural sinus thrombosis (
         <a class="graphic graphic_figure graphicRef83204" href="/z/d/graphic/83204.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Complications'
         </a>
         .)
        </p>
        <p>
         Acute mastoiditis complicated by isolated facial nerve paralysis can be managed conservatively initially [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="local">
          'Uncomplicated disease'
         </a>
         above.)
        </p>
        <p>
         Practice varies regarding management of children with subperiosteal abscess. We typically perform simple mastoidectomy (in conjunction with antibiotic therapy and myringotomy) if there are clinical findings indicating the presence of a subperiosteal abscess (eg, postauricular fluctuance or mass (
         <a class="graphic graphic_picture graphicRef70910" href="/z/d/graphic/70910.html" rel="external">
          picture 2
         </a>
         )) or if computed tomography (CT), if performed, shows a sizable collection. In the absence of clinical findings, patients with only a small subperiosteal collection on CT can be managed conservatively initially [
         <a href="#rid9">
          9,12,14
         </a>
         ]. Some experts favor postauricular aspiration as the initial procedure for children with a small subperiosteal abscess [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Children with suppurative intratemporal or intracranial complications may require additional surgical intervention(s) to address the specific complication (eg, drainage of intratemporal or intracranial collections) [
         <a href="#rid1">
          1,7
         </a>
         ]. (See
         <a class="local">
          'Drainage'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          ANTIMICROBIAL THERAPY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The treatment of mastoiditis requires parenteral antimicrobial therapy. However, antimicrobial therapy alone usually is not sufficient, particularly in the later stages of the disease process, when it may be difficult to achieve adequate antibiotic levels in the bony tissue [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Empiric therapy
         </strong>
         – Choice of empiric antimicrobial therapy for children with acute mastoiditis depends upon whether there is a history of recurrent acute otitis media (AOM) or recent antibiotic therapy (
         <a class="graphic graphic_table graphicRef61644" href="/z/d/graphic/61644.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Children
         <strong>
          without
         </strong>
         recurrent AOM or recent antibiotics – For children without a history of recurrent AOM or recent antibiotic administration (ie, within six months), we suggest empiric antimicrobial therapy with
         <a class="drug drug_pediatric" data-topicid="12695" href="/z/d/drug information/12695.html" rel="external">
          ampicillin-sulbactam
         </a>
         (50 mg/kg intravenously [IV] every six hours; maximum daily dose 12 g) (
         <a class="graphic graphic_table graphicRef61644" href="/z/d/graphic/61644.html" rel="external">
          table 2
         </a>
         ). The most frequent bacterial pathogens are
         <em>
          S
         </em>
         .
         <em>
          pneumoniae
         </em>
         and
         <em>
          S
         </em>
         .
         <em>
          pyogenes
         </em>
         .
         <em>
          F
         </em>
         .
         <em>
          necrophorum
         </em>
         ,
         <em>
          H
         </em>
         .
         <em>
          influenzae
         </em>
         (nontypeable), and
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         (including methicillin-resistant
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         ) are recovered less often.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Children
         <strong>
          with
         </strong>
         recurrent AOM or recent antibiotics – For children with a history of recurrent AOM (most recent episode within six months) or recent antibiotic use, we suggest
         <a class="drug drug_pediatric" data-topicid="12708" href="/z/d/drug information/12708.html" rel="external">
          piperacillin-tazobactam
         </a>
         at 75 mg/kg IV every six hours (maximum daily dose 16 g). Suggested empiric regimens are summarized in the table (
         <a class="graphic graphic_table graphicRef61644" href="/z/d/graphic/61644.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional or alternative antimicrobial agents may be warranted in some circumstances, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If there are clinical signs of sepsis at the time of presentation, in whom
         <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">
          vancomycin
         </a>
         should be added to the empiric regimen (see
         <a class="medical medical_review" href="/z/d/html/85767.html" rel="external">
          "Septic shock in children in resource-abundant settings: Rapid recognition and initial resuscitation (first hour)", section on 'Empiric regimens'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If there are specific complications (eg, intracranial abscess abscess) (see
         <a class="medical medical_review" href="/z/d/html/103898.html" rel="external">
          "Intracranial epidural abscess", section on 'Empiric antimicrobial therapy'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If the child does not improve with the initial empiric regimen
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogen-specific therapy
         </strong>
         – When results of culture and susceptibility testing are available, antimicrobial therapy should be adjusted accordingly. Common pathogens include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          S
         </em>
         .
         <em>
          pneumoniae
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/3168.html" rel="external">
          "Invasive pneumococcal (Streptococcus pneumoniae) infections and bacteremia in adults", section on 'Treatment'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          S
         </em>
         .
         <em>
          pyogenes
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/6068.html" rel="external">
          "Invasive group A streptococcal infections in children", section on 'Treatment'
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         (including methicillin-resistant
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         ) (see
         <a class="medical medical_review" href="/z/d/html/6057.html" rel="external">
          "
          <i>
           Staphylococcus aureus
          </i>
          in children: Overview of treatment of invasive infections"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration of therapy
         </strong>
         – We usually treat with IV antibiotics for 7 to 10 days and then transition to oral antibiotics to complete a four-week course (the usual duration for treatment of osteomyelitis). Transition to oral antibiotics can occur when the child has improved clinically and culture and susceptibility results are available [
         <a href="#rid20">
          20-22
         </a>
         ]. In observational studies, the duration of treatment varies depending on the severity of the infection, with extended courses for children with intracranial complications [
         <a href="#rid14">
          14,23
         </a>
         ]. Indirect evidence supporting a four-week duration of antibiotic therapy is provided from studies in children with hematogenous osteomyelitis, which are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5958.html" rel="external">
          "Hematogenous osteomyelitis in children: Management", section on 'Total duration'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          DRAINAGE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of acute mastoiditis generally requires the drainage of pus from the middle ear and/or mastoid cavity. Antimicrobial therapy alone is usually not sufficient, particularly in the later stages of the disease process, when it may be difficult to achieve adequate antibiotic levels in the bony tissue [
         <a href="#rid8">
          8
         </a>
         ]. In addition, early drainage may interrupt the pathologic process and prevent complications [
         <a href="#rid8">
          8
         </a>
         ]. Although there are reports of successful treatment without tympanocentesis or myringotomy [
         <a href="#rid3">
          3
         </a>
         ], we do not advocate such an approach, since aspiration of middle ear fluid is crucial in guiding definitive antimicrobial therapy.
        </p>
        <p>
         Practice varies from center to center regarding the use of different drainage procedures (tympanocentesis, myringotomy, myringotomy with placement of tympanostomy tube [TT], mastoidectomy) based on the pathologic stage (acute mastoiditis with periostitis versus coalescent mastoiditis) and presence or absence and type of complications [
         <a href="#rid1">
          1,7,24
         </a>
         ]. (See
         <a class="local">
          'Management approach'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tympanocentesis – At a minimum, tympanocentesis should be performed in all children with mastoiditis to obtain middle ear fluid for culture and susceptibility testing [
         <a href="#rid1">
          1
         </a>
         ]. Obtaining samples for culture is extremely important to allow therapy to be tailored to the individual patient. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Microbiologic studies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myringotomy – Myringotomy (surgical perforation of the tympanic membrane) permits drainage of the middle ear; it may be performed with or without placement of a TT. Myringotomy permits drainage of the mastoid if the aditus ad antrum is not blocked (
         <a class="graphic graphic_figure graphicRef74487" href="/z/d/graphic/74487.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. A wide-field, large myringotomy should be performed in children with acute mastoid osteitis to ensure adequate drainage [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TT placement – TTs permit drainage over a longer duration than myringotomy alone [
         <a href="#rid1">
          1
         </a>
         ]. At most institutions, it is standard to place a TT when myringotomy is performed to ensure sustained drainage. (See
         <a class="medical medical_review" href="/z/d/html/6305.html" rel="external">
          "Overview of tympanostomy tube placement, postoperative care, and complications in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence", section on 'Tympanostomy tubes'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87008.html" rel="external">
          "Otitis media with effusion (serous otitis media) in children: Management", section on 'Tympanostomy tubes'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mastoidectomy – Mastoidectomy is the surgical removal of the mastoid cortical bone and underlying air cells. In simple mastoidectomy (also called cortical, complete, or canal-wall-up mastoidectomy), the posterior portion of the external auditory canal is preserved. In radical mastoidectomy (also called canal-wall-down mastoidectomy), the posterior portion of the external auditory canal is sacrificed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Simple mastoidectomy is performed to clean out the mastoid infection, open the aditus ad antrum, and provide external drainage [
         <a href="#rid1">
          1
         </a>
         ]. Radical mastoidectomy is performed only when there is no clinical response to simple mastoidectomy, as evidenced by continued otorrhea or pain [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Indications for mastoidectomy may include [
         <a href="#rid1">
          1,6,24
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Clinical findings consistent with subperiosteal abscess, such as postauricular fluctuance or mass (
         <a class="graphic graphic_picture graphicRef70910" href="/z/d/graphic/70910.html" rel="external">
          picture 2
         </a>
         ), regardless of CT findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other suppurative complications of acute mastoiditis (eg, Bezold abscess, osteomyelitis involving other parts of the skull, suppurative labyrinthitis, meningitis, subdural abscess, epidural abscess, brain abscess, cerebellar abscess, or septic dural sinus thrombosis) (
         <a class="graphic graphic_figure graphicRef83204" href="/z/d/graphic/83204.html" rel="external">
          figure 1
         </a>
         ) – Suppurative intratemporal or intracranial complications may require additional surgical intervention(s) to address the specific complication (eg, drainage of intratemporal or intracranial collections). (See
         <a class="medical medical_review" href="/z/d/html/103898.html" rel="external">
          "Intracranial epidural abscess", section on 'Management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3410.html" rel="external">
          "Septic dural sinus thrombosis", section on 'Surgery'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         CT evidence of a sizable fluid collection, mastoid air cell coalescence, or cortical bone erosion – In general, imaging is warranted only in patients with clinical findings suggestive of an extra- or intracranial complication and such patients typically have another indication for mastoidectomy. However, if CT imaging is performed without an indication and demonstrates one of these concerning findings, mastoidectomy is usually warranted even in the absence of other clinical findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute mastoiditis in a child with chronic suppurative otitis media or cholesteatoma. (See
         <a class="medical medical_review" href="/z/d/html/91002.html" rel="external">
          "Chronic suppurative otitis media (CSOM): Treatment, complications, and prevention", section on 'Surgery'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6306.html" rel="external">
          "Cholesteatoma in children", section on 'Surgical treatment'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Progression of postauricular swelling or fluctuance or persistence of fever, ear pain, or drainage despite appropriate intravenous (IV) antimicrobial therapy and tympanocentesis/myringotomy.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          TREATMENT RESPONSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The response to treatment of acute mastoiditis is monitored through serial examination of the postauricular region, external auditory canal, and tympanic membrane for improvement or resolution of clinical findings [
         <a href="#rid1">
          1,7
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Otalgia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postauricular tenderness, erythema, swelling, fluctuance, or mass
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protrusion of the auricle
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sagging or edema (narrowing) of the external auditory canal
        </p>
        <p>
        </p>
        <p>
         In patients with acute mastoiditis with periostitis, periosteal involvement usually resolves within 24 to 48 hours after tympanocentesis/myringotomy and initiation of adequate antimicrobial therapy [
         <a href="#rid1">
          1
         </a>
         ]. Mastoidectomy is indicated in children who do not demonstrate adequate treatment response after 24 to 48 hours. Imaging of the temporal bone also may be indicated (to evaluate the development of intratemporal complications) [
         <a href="#rid1">
          1,6
         </a>
         ].
        </p>
        <p>
         Similarly, patients with acute coalescent mastoiditis or complications who have been treated with intravenous (IV) antibiotics, myringotomy, and mastoidectomy usually demonstrate clinical improvement within 24 to 48 hours of initiation of treatment. Radical mastoidectomy may be indicated for patients with persistent symptoms [
         <a href="#rid1">
          1
         </a>
         ]. Imaging (if not previously performed) or repeat imaging of the temporal bone also may be warranted in patients with persistent or worsening symptoms to evaluate the development of intratemporal complications [
         <a href="#rid1">
          1,6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          OUTCOME
         </span>
         <span class="headingEndMark">
          —
         </span>
         The outcome of acute mastoiditis depends upon the extent of infection [
         <a href="#rid6">
          6,17
         </a>
         ]. Most children with acute mastoiditis that is appropriately treated early in the course recover without complications or long-term sequelae (eg, hearing loss) [
         <a href="#rid9">
          9,17
         </a>
         ]. Intracranial extension may be associated with permanent neurologic deficits or death. Hearing loss is uncommon but can occur, particularly if treatment is delayed or if there is a history of recurrent acute or chronic otitis media. Hearing loss can be conductive, sensorineural, or mixed. It is most often conductive due to damage to the middle ear, though sensorineural hearing loss can occur from suppurative labyrinthitis causing damage to the cochlea [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Audiology should be performed during the convalescence of children with acute mastoiditis to determine if they have hearing loss and, if so, whether it is conductive or sensorineural [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation", section on 'Formal audiology'
         </a>
         .)
        </p>
        <p>
         Children who develop intracranial complications of acute mastoiditis should be followed for the development of adverse neurologic and/or otologic effects (eg, sensorineural hearing loss). (See
         <a class="medical medical_review" href="/z/d/html/615.html" rel="external">
          "Developmental-behavioral surveillance and screening in primary care"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6297.html" rel="external">
          "Hearing loss in children: Screening and evaluation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early, adequate treatment of acute otitis media (AOM) reduces the risk of developing mastoiditis but does not eliminate it altogether [
         <a href="#rid4">
          4,8,25-27
         </a>
         ]. In a retrospective cohort study, the rate of mastoiditis was 1.8 versus 3.8 per 10,000 episodes of AOM that were treated and not treated with antibiotics, respectively [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Other possible preventive strategies include interventions to prevent recurrent AOM and immunization with the pneumococcal conjugate vaccine. These are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5998.html" rel="external">
          "Acute otitis media in children: Prevention of recurrence"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6053.html" rel="external">
          "Pneumococcal vaccination in children"
         </a>
         .)
        </p>
        <p>
         Prompt treatment of acute mastoiditis and early evaluation of persistent ear drainage, ear pain, or AOM that is not responding to antimicrobial therapy may decrease the risk of developing complications of mastoiditis [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H574321276">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/109085.html" rel="external">
          "Society guideline links: Acute otitis media, otitis media with effusion, and external otitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Acute mastoiditis is a suppurative infection of the mastoid air cells with symptoms of less than one month's duration. It may be uncomplicated or complicated (ie, associated with one or more extra- or intracranial complications (
         <a class="graphic graphic_figure graphicRef83204" href="/z/d/graphic/83204.html" rel="external">
          figure 1
         </a>
         )). (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         – The bacterial species most often implicated in acute mastoiditis are
         <em>
          Streptococcus
         </em>
         <em>
          pneumoniae
         </em>
         and
         <em>
          Streptococcus
         </em>
         <em>
          pyogenes
         </em>
         . Less often,
         <em>
          Fusobacterium
         </em>
         <em>
          necrophorum
         </em>
         ,
         <em>
          Haemophilus
         </em>
         <em>
          influenzae
         </em>
         (nontypeable), and
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         are recovered.
         <em>
          Pseudomonas
         </em>
         <em>
          aeruginosa
         </em>
         is a consideration for children with a history of recurrent acute otitis media (AOM) or recent antibiotic use. (See
         <a class="medical medical_review" href="/z/d/html/6062.html" rel="external">
          "Acute mastoiditis in children: Clinical features and diagnosis", section on 'Microbiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical consultation
         </strong>
         – Consultation with an otolaryngologist should occur early in the disease course. Consultation with a neurosurgeon may be warranted for children with clinical or radiologic evidence of an intracranial complication. In addition, consultation with a pediatric infectious disease expert can help guide antimicrobial therapy. (See
         <a class="local">
          'Referral'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management approach
         </strong>
         – The treatment of acute mastoiditis depends upon the pathologic stage as well as presence or absence and type of complications. Antimicrobial therapy and drainage of the middle ear and mastoid are the cornerstones of therapy (
         <a class="graphic graphic_table graphicRef119748" href="/z/d/graphic/119748.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Management approach'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Uncomplicated disease
         </strong>
         – For children with uncomplicated acute or subacute (masked) mastoiditis, we suggest initial conservative management rather than aggressive surgical management (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Conservative management consists of intravenous (IV) antimicrobial therapy and middle ear drainage with myringotomy (with or without placement of a tympanostomy tube [TT]). Patients should be monitored daily for clinical response, and mastoidectomy should be performed if there is no clinical improvement within 48 hours. (See
         <a class="local">
          'Uncomplicated disease'
         </a>
         above and
         <a class="local">
          'Treatment response'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Complicated disease
         </strong>
         – For children with suppurative extracranial or intracranial complications of acute mastoiditis other than facial nerve paralysis (
         <a class="graphic graphic_figure graphicRef83204" href="/z/d/graphic/83204.html" rel="external">
          figure 1
         </a>
         ), we suggest initial aggressive surgical management with mastoidectomy in addition to IV antimicrobial therapy and myringotomy (with TT insertion) rather than conservative therapy alone (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Acute mastoiditis complicated by isolated facial nerve paralysis can be managed conservatively initially. (See
         <a class="local">
          'Complicated disease'
         </a>
         above and
         <a class="local">
          'Drainage'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Empiric antibiotic choice
         </strong>
         – Treatment of mastoiditis requires parenteral antimicrobial therapy. The choice of initial empiric antimicrobial therapy for children with acute mastoiditis depends upon whether there is a history of recurrent AOM or recent antibiotic therapy (
         <a class="graphic graphic_table graphicRef61644" href="/z/d/graphic/61644.html" rel="external">
          table 2
         </a>
         ) (see
         <a class="local">
          'Antimicrobial therapy'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For children without a history of recurrent AOM or recent antibiotic administration, we suggest empiric antimicrobial therapy with
         <a class="drug drug_pediatric" data-topicid="12695" href="/z/d/drug information/12695.html" rel="external">
          ampicillin-sulbactam
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For children with a history of recurrent AOM or recent antibiotic use, we suggest
         <a class="drug drug_pediatric" data-topicid="12708" href="/z/d/drug information/12708.html" rel="external">
          piperacillin-tazobactam
         </a>
         as initial empiric therapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ) because of its activity against
         <em>
          P
         </em>
         .
         <em>
          aeruginosa
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tailoring antibiotics and duration of therapy
         </strong>
         – When results of culture and susceptibility testing are available, antimicrobial therapy should be adjusted accordingly. The total duration of antimicrobial therapy is four weeks. Transition to oral antibiotics can occur when the child has improved clinically and culture and susceptibility results are available. (See
         <a class="local">
          'Antimicrobial therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcome
         </strong>
         – Most children with acute mastoiditis that is appropriately treated early in the course recover without complications or long-term sequelae. Intracranial extension may be associated with permanent neurologic deficits or death. Permanent hearing loss is an uncommon complication. (See
         <a class="local">
          'Outcome'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Pediatric otolaryngology, 4th ed, Bluestone CD, Casselbrant ML, Stool SE, et al (Eds), Saunders, Philadelphia 2003. p.687.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bahadori RS, Schwartz RH, Ziai M. Acute mastoiditis in children: an increase in frequency in Northern Virginia. Pediatr Infect Dis J 2000; 19:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geva A, Oestreicher-Kedem Y, Fishman G, et al. Conservative management of acute mastoiditis in children. Int J Pediatr Otorhinolaryngol 2008; 72:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pang LH, Barakate MS, Havas TE. Mastoiditis in a paediatric population: a review of 11 years experience in management. Int J Pediatr Otorhinolaryngol 2009; 73:1520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt GR, Gates GA. Masked mastoiditis. Laryngoscope 1983; 93:1034.
          </a>
         </li>
         <li class="breakAll">
          Cherry JD, Vahabzadeh-Hagh AM, Shapiro NL. Mastoiditis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison GJ, Kaplan SL, et al (Eds), Elsevier, 2019. p.169.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin HW, Shargorodsky J, Gopen Q. Clinical strategies for the management of acute mastoiditis in the pediatric population. Clin Pediatr (Phila) 2010; 49:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luntz M, Brodsky A, Nusem S, et al. Acute mastoiditis--the antibiotic era: a multicenter study. Int J Pediatr Otorhinolaryngol 2001; 57:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein NA, Casselbrant ML, Bluestone CD, Kurs-Lasky M. Intratemporal complications of acute otitis media in infants and children. Otolaryngol Head Neck Surg 1998; 119:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamir S, Schwartz Y, Peleg U, et al. Acute mastoiditis in children: is computed tomography always necessary? Ann Otol Rhinol Laryngol 2009; 118:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spratley J, Silveira H, Alvarez I, Pais-Clemente M. Acute mastoiditis in children: review of the current status. Int J Pediatr Otorhinolaryngol 2000; 56:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen-Kerem R, Uri N, Rennert H, et al. Acute mastoiditis in children: is surgical treatment necessary? J Laryngol Otol 1999; 113:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kvestad E, Kvaerner KJ, Mair IW. Acute mastoiditis: predictors for surgery. Int J Pediatr Otorhinolaryngol 2000; 52:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakhos D, Trijolet JP, Morinière S, et al. Conservative management of acute mastoiditis in children. Arch Otolaryngol Head Neck Surg 2011; 137:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niv A, Nash M, Peiser J, et al. Outpatient management of acute mastoiditis with periosteitis in children. Int J Pediatr Otorhinolaryngol 1998; 46:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loh R, Phua M, Shaw CL. Management of paediatric acute mastoiditis: systematic review. J Laryngol Otol 2018; 132:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson KJ. Mastoiditis. Pediatr Rev 2009; 30:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor MF, Berkowitz RG. Indications for mastoidectomy in acute mastoiditis in children. Ann Otol Rhinol Laryngol 2004; 113:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahav J, Handzel O, Gertler R, et al. Postauricular needle aspiration of subperiosteal abscess in acute mastoiditis. Ann Otol Rhinol Laryngol 2005; 114:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchisio P, Bianchini S, Villani A, et al. Diagnosis and management of acute mastoiditis in a cohort of Italian children. Expert Rev Anti Infect Ther 2014; 12:1541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groth A, Enoksson F, Hultcrantz M, et al. Acute mastoiditis in children aged 0-16 years--a national study of 678 cases in Sweden comparing different age groups. Int J Pediatr Otorhinolaryngol 2012; 76:1494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorphe P, de Barros A, Choussy O, et al. Acute mastoiditis in children: 10 years experience in a French tertiary university referral center. Eur Arch Otorhinolaryngol 2012; 269:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Psarommatis IM, Voudouris C, Douros K, et al. Algorithmic management of pediatric acute mastoiditis. Int J Pediatr Otorhinolaryngol 2012; 76:791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zanetti D, Nassif N. Indications for surgery in acute mastoiditis and their complications in children. Int J Pediatr Otorhinolaryngol 2006; 70:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson PL, Gilbert RE, Long PF, et al. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database. Pediatrics 2009; 123:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Aardweg MT, Rovers MM, de Ru JA, et al. A systematic review of diagnostic criteria for acute mastoiditis in children. Otol Neurotol 2008; 29:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mustafa A, Debry Ch, Wiorowski M, et al. Treatment of acute mastoiditis: report of 31 cases over a ten year period. Rev Laryngol Otol Rhinol (Bord) 2004; 125:165.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6036 Version 21.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Pediatric otolaryngology, 4th ed, Bluestone CD, Casselbrant ML, Stool SE, et al (Eds), Saunders, Philadelphia 2003. p.687.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10749461" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Acute mastoiditis in children: an increase in frequency in Northern Virginia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18304656" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Conservative management of acute mastoiditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19758711" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Mastoiditis in a paediatric population: a review of 11 years experience in management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6877011" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Masked mastoiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6877011" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Masked mastoiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19734439" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Clinical strategies for the management of acute mastoiditis in the pediatric population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11165635" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Acute mastoiditis--the antibiotic era: a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9807067" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Intratemporal complications of acute otitis media in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19746754" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Acute mastoiditis in children: is computed tomography always necessary?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11074113" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Acute mastoiditis in children: review of the current status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767920" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Acute mastoiditis in children: is surgical treatment necessary?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767462" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Acute mastoiditis: predictors for surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21502472" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Conservative management of acute mastoiditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10190699" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Outpatient management of acute mastoiditis with periosteitis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28879826" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Management of paediatric acute mastoiditis: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19487433" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Mastoiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14763577" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Indications for mastoidectomy in acute mastoiditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15895789" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Postauricular needle aspiration of subperiosteal abscess in acute mastoiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25382701" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Diagnosis and management of acute mastoiditis in a cohort of Italian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22832239" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Acute mastoiditis in children aged 0-16 years--a national study of 678 cases in Sweden comparing different age groups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21713452" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Acute mastoiditis in children: 10 years experience in a French tertiary university referral center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22405736" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Algorithmic management of pediatric acute mastoiditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16413617" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Indications for surgery in acute mastoiditis and their complications in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19171605" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18617870" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : A systematic review of diagnostic criteria for acute mastoiditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15602860" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Treatment of acute mastoiditis: report of 31 cases over a ten year period.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
